Vivienne was a board member of UK Research & Innovation (UKRI) which was formed in 2018 to bring together the 7 Research Councils, Innovate UK and Research England. UKRI’s annual budget is over £7 billion. She completed her term in 2021. When she was appointed she said
‘This is an awesome responsibility. I am determined to do the best I can for science, for the public and for the UK. I hope in particular to represent the interests of early career researchers in the arts, humanities and sciences’, she says
Vivienne is proud to have been Vice Chair of the UCL Council. In the last Research Excellence Framework, UCL surpassed both Oxford and Cambridge as a powerhouse of research. She completed over ten years of service on the UCL Council in 2015.
She has also been member of the MRC Council, completing her maximum term in 2016, and continued to serve on a number of its committees.
In the past she has been a member of the Joint Committee on Vaccination and Immunisation (JCVI), was a member of the Duff Enquiry, investigating the TGN1412 incident, was a member of the group reviewing the diagnostics division of the MHRA, was a member of the Organ Donor Taskforce and also of subsequent investigations into Presumed Consent and sale of organs abroad. She was a member of the group reviewing cosmetic interventions for the Department of Health. During the pandemic she chaired the DECOVID Data Trust committee and was a member of the NHS Digitrials board.
She was very involved with the setting up of the Science Media Centre and the Cheltenham Science Festival. She was chair in 2017-2019 and continues to be involved in its programme.
Whilst responsible for CSR for the GUS Group, she set up the Prostate Cancer Charter for Action and subsequently, the Cancer52 group. She has a deep knowledge of patient groups and patient engagement and involvement.